logo
ENFRع
Elara Caring Appoints Ananth Mohan As Chief Executive Officer

Elara Caring Appoints Ananth Mohan As Chief Executive Officer

Associated Press25-06-2025
DALLAS, June 25, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE
Elara Caring Appoints Ananth Mohan As Chief Executive Officer
Elara Caring, a leading national provider of home-based care, today announced that Ananth Mohan, the company's former Chief Operating Officer, has been appointed Chief Executive Officer. He succeeds Scott Powers, who is leaving the company after nearly six years as CEO.
Under Powers' leadership, Elara Caring evolved into one of the most trusted and integrated providers of high-acuity care in the home. He helped unite the organization under a shared mission, strengthened its infrastructure, and led significant growth across clinical and non-clinical services, technology, and talent. His tenure has been marked by a deep commitment to delivering compassionate, high-quality care wherever people call home.
'It's been a privilege to lead Elara through a period of meaningful growth and impact,' said Powers. 'I have every confidence that Ananth will build on this momentum and continue to advance Elara's mission with vision and heart.'
'Scott helped lay the foundation for the Elara we are today—strong, united, and purpose-driven,' said Mohan. 'I'm honored to step into this role and accelerate our growth and expand and enhance the impact of our life-changing mission.'
Mohan brings more than two decades of experience leading complex healthcare organizations and has served as Elara Caring's Chief Operating Officer since 2021. In that role, he led Elara's business units and played a critical role in enterprise-wide transformation, working closely with clinical teams, operational leaders, and partners to drive performance and expand access to care.
'We're entering an exciting new chapter—one that builds on our strengths and positions us for continued innovation and growth,' Mohan added. 'Our focus remains on delivering exceptional care in the home, supporting our team members, and ensuring a more connected experience across the full spectrum of our services—from skilled home health and hospice to behavioral health and personal care services.'
At the core of Elara Caring's strategy is a simple but powerful belief: the home is where healing happens. The company is committed to expanding its footprint, scaling integrated services, and continuing to invest in technologies that empower its teams and improve patient outcomes.
About Elara Caring
Elara Caring is among the nation's leading providers of high-quality, value-based home care, offering Skilled Home Health, Hospice, Personal Care Services, Behavioral Health, and Palliative Care. With a footprint in 18 states, it serves more than 60,000 patients and clients daily across 200 locations. At Elara, care is delivered by skilled, compassionate professionals dedicated to supporting patients with expertise and empathy. Through care innovation and a commitment to excellence, Elara ensures patients receive the right care when and where they need it most.
Visit our website to learn more.
Follow us on LinkedIn for updates.
Zach Hausauer | Senior Director, Communications Elara Caring 7758423223 [email protected]

Hashtags

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The Lovesac Company's (NASDAQ:LOVE) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
The Lovesac Company's (NASDAQ:LOVE) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Yahoo

time34 minutes ago

  • Yahoo

The Lovesac Company's (NASDAQ:LOVE) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Lovesac (NASDAQ:LOVE) has had a great run on the share market with its stock up by a significant 34% over the last three months. But the company's key financial indicators appear to be differing across the board and that makes us question whether or not the company's current share price momentum can be maintained. Specifically, we decided to study Lovesac's ROE in this article. Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors' money. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Return on equity can be calculated by using the formula: Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity So, based on the above formula, the ROE for Lovesac is: 6.8% = US$14m ÷ US$201m (Based on the trailing twelve months to May 2025). The 'return' refers to a company's earnings over the last year. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.07. View our latest analysis for Lovesac We have already established that ROE serves as an efficient profit-generating gauge for a company's future earnings. We now need to evaluate how much profit the company reinvests or "retains" for future growth which then gives us an idea about the growth potential of the company. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics. At first glance, Lovesac's ROE doesn't look very promising. Next, when compared to the average industry ROE of 15%, the company's ROE leaves us feeling even less enthusiastic. As a result, Lovesac reported a very low income growth of 4.0% over the past five years. As a next step, we compared Lovesac's net income growth with the industry and were disappointed to see that the company's growth is lower than the industry average growth of 11% in the same period. The basis for attaching value to a company is, to a great extent, tied to its earnings growth. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. Is LOVE fairly valued? This infographic on the company's intrinsic value has everything you need to know. Lovesac doesn't pay any regular dividends, meaning that potentially all of its profits are being reinvested in the business. However, this doesn't explain the low earnings growth the company has seen. So there could be some other explanation in that regard. For instance, the company's business may be deteriorating. Overall, we have mixed feelings about Lovesac. While the company does have a high rate of profit retention, its low rate of return is probably hampering its earnings growth. Having said that, looking at the current analyst estimates, we found that the company's earnings are expected to gain momentum. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company. — Investing narratives with Fair Values Suncorp's Next Chapter: Insurance-Only and Ready to Grow By Robbo – Community Contributor Fair Value Estimated: A$22.83 · 0.1% Overvalued Thyssenkrupp Nucera Will Achieve Double-Digit Profits by 2030 Boosted by Hydrogen Growth By Chris1 – Community Contributor Fair Value Estimated: €14.40 · 0.3% Overvalued Tesla's Nvidia Moment – The AI & Robotics Inflection Point By BlackGoat – Community Contributor Fair Value Estimated: $359.72 · 0.1% Overvalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store